VeriMomHamilelikte sulindac kullanmaktan kaçınmalı mıyım? | VeriMom
Sulindac is an NSAID with human and animal evidence of fetal harm (e.g., fetal renal dysfunction/oligohydramnios and ductus arteriosus effects that are class warnings for NSAIDs) and is listed by some safety sources as suspected/known developmental hazard; therefore reproductive hazard is suspected (H361 level evidence from registrants/SDSs and clinical reports). Mechanism is demonstrated COX/prostaglandin inhibition with known placental/fetal effects. Topical cosmetic use would give negligible systemic exposure compared with oral dosing; therefore exposure from a cosmetic topical route is judged negligible for adults. (Sources: LactMed (NLM), StatPearls/NCBI review of NSAIDs in pregnancy, clinical/toxicology studies; SDSs listing H361).
ECHA regulatory hazard statements
- •H360
- •H361
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- sulindac hamilelikte güvenli mi?
- Sulindac is an NSAID with human and animal evidence of fetal harm (e.g., fetal renal dysfunction/oligohydramnios and ductus arteriosus effects that are class warnings for NSAIDs) and is listed by some safety sources as suspected/known developmental hazard; therefore reproductive hazard is suspected (H361 level evidence from registrants/SDSs and clinical reports). Mechanism is demonstrated COX/prostaglandin inhibition with known placental/fetal effects. Topical cosmetic use would give negligible systemic exposure compared with oral dosing; therefore exposure from a cosmetic topical route is judged negligible for adults. (Sources: LactMed (NLM), StatPearls/NCBI review of NSAIDs in pregnancy, clinical/toxicology studies; SDSs listing H361).
- sulindac emzirirken güvenli mi?
- Breastfeeding guidance (LactMed) advises avoidance or preference for alternatives because data are lacking and sulindac has a long half‑life and metabolites; systemic maternal exposure can transfer drug/metabolites to milk. Mechanism (COX inhibition/systemic distribution) is established. Topical cosmetic use would be expected to give negligible maternal systemic exposure, so direct exposure via milk from cosmetic use is expected to be negligible. (Sources: LactMed, NCBI reviews, SDSs).
- sulindac bebek cildi için güvenli mi?
- No infant‑specific dermal toxicity data were found. Hazard and mechanism remain the same (suspected reproductive/developmental hazard via prostaglandin inhibition). For baby skin (0–3 yr) exposure score is increased by +1 relative to adult because infant skin barrier is immature and systemic absorption may be greater if measurable; although topical cosmetic use of sulindac is uncommon and absolute absorption is likely low, infant exposure via dermal application cannot be assumed negligible without formulation data. (Sources: LactMed, NCBI/StatPearls on NSAIDs; SDSs/EHS listings).
- VeriMom sulindac nasıl puanlıyor?
- VeriMom sulindac'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 27/100 (yüksek risk) olarak puanlar.
- Hamilelikte sulindac yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.